Gian Lodovico Rapaccini

Author

Also Known As

Cristiano Caruso, G L Rapaccini, G RAPACCINI, G Rapaccini, G. L. Rapaccini, G. Lodovico Rapaccini, G. Rapaccini, G.L. Rapaccini, Gian L. Rapaccini, Gian Lodovico Rapaccini

111

Publications

3.9K

Citations

H-Index

Concepts

All Affiliations

Università Cattolica del Sacro Cuore Istituti di Ricovero e Cura a Carattere Scientifico University of Padua Agostino Gemelli University Polyclinic Ospedale di Belcolle

About

Gian Lodovico Rapaccini is an author at Università Cattolica del Sacro Cuore specializing in medicine, hepatology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	23	1.9K
2	Health Sciences	3	3	140
3	Allergy	2	2	119
4	Public Health	1	1	120
5	Biostatistics	1	1	120

Gian Lodovico Rapaccini

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
Thrombotic risk factors in patients with liver cirrhosis: Correlation with MELD scoring system and portal vein thrombosis development Maria Assunta Zocco, Enrico Di Stasio, Raimondo De Cristofaro, Journal of Hepatology HepatologyThrombotic Risk FactorsLiver PhysiologyGastroenterologyCirrhosis	2009	465
Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules Eleonora Terzi, Massimo Iavarone, Maurizio Pompili, Journal of Hepatology HepatologyHistopathologyPathologyHepatitisLiver Disease	2017	251
Prognosis of untreated hepatocellular carcinoma Edoardo G. Giannini, Fabio Farinati, Francesca Ciccarese, Hepatology	2014	241
Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: A multicentre study Alessandro Vitale, Patrizia Burra, Anna Chiara Frigo, Journal of Hepatology Liver ResectionSurgical OncologyHepatologyMedicineMulticentre Study	2014	208
Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma Fabio Farinati, Alessandro Vitale, Gaya Spolverato, PLoS Medicine	2016	140
Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice Edoardo G. Giannini, Laura Bucci, Francesca Garuti, Hepatology	2017	122
Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma Alessandro Cucchetti, Franco Trevisani, Anna Pecorelli, Journal of Hepatology Early DiagnosisHepatologyCancer EpidemiologyCancer DetectionCancer Screening	2014	120
Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti‐TNF alpha: 5‐year follow‐up study Daniela Pugliese, Luisa Guidi, Pietro Manuel Ferraro, Alimentary Pharmacology & Therapeutics	2015	110
Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma Giuseppe Cabibbo, Salvatore Petta, Marco Barbàra, Journal of Hepatology HepatologyHepatitis CViral HepatitisLiver PhysiologyPathology	2017	107
Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: An open-label pilot study Alessandro Armuzzi, Carla Felice, Alfredo Papa, Journal of Crohn s and Colitis	2013	105

Page 1